RAndomized trial of Legflow PaclItaxel Eluting Balloon (LPEB) with stentplacement vs. stanDard percutaneous transluminal angioplasty (PTA) with stentplacement for the treatment of intermediate (>5 cm and < 15 cm) and long (>15 cm) lesions of the superficial femoral artery (SFA): The RAPID trial

Trial Profile

RAndomized trial of Legflow PaclItaxel Eluting Balloon (LPEB) with stentplacement vs. stanDard percutaneous transluminal angioplasty (PTA) with stentplacement for the treatment of intermediate (>5 cm and < 15 cm) and long (>15 cm) lesions of the superficial femoral artery (SFA): The RAPID trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 May 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms RAPID
  • Most Recent Events

    • 13 Jan 2014 Status changed from recruiting to completed as reported in ISRCTN: Current Controlled Trials record.
    • 07 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top